Abstract
Many immune responses are dependent on the four members of the leukocyte integrin family of surface receptors. Organ transplantation triggers a range of immune responses aimed at rejecting the donor tissue. Engagement of cells of the immune system including T cells, B cells, and antigen presenting cells with each other or with the donor organ is an essential element of the rejection cascade, and this engagement is mediated by adhesions through the leukocyte integrins and their ligands. This review will first focus on the molecular mechanisms that regulate rapid activation of the leukocyte integrins by inside-out signaling that results in changes in receptor clustering on the leukocyte membrane and ligand affinity. Longer lasting changes in receptor expression through transcriptional mechanisms will also be discussed. The role of these receptors in organ transplant rejection, graft-versus-host disease, and ischemic reperfusion injury will also be reviewed. The potential of anti-adhesion therapy to prolong organ transplant survival will be discussed in both animal and patient studies.
Keywords: leukocyte integrins, transplantation, ischemic reperfusion injury, graft-versus-host
Current Medicinal Chemistry
Title: Expression and Function of the Leukocyte Integrins in Organ Transplant Rejection
Volume: 11 Issue: 4
Author(s): John D. Noti
Affiliation:
Keywords: leukocyte integrins, transplantation, ischemic reperfusion injury, graft-versus-host
Abstract: Many immune responses are dependent on the four members of the leukocyte integrin family of surface receptors. Organ transplantation triggers a range of immune responses aimed at rejecting the donor tissue. Engagement of cells of the immune system including T cells, B cells, and antigen presenting cells with each other or with the donor organ is an essential element of the rejection cascade, and this engagement is mediated by adhesions through the leukocyte integrins and their ligands. This review will first focus on the molecular mechanisms that regulate rapid activation of the leukocyte integrins by inside-out signaling that results in changes in receptor clustering on the leukocyte membrane and ligand affinity. Longer lasting changes in receptor expression through transcriptional mechanisms will also be discussed. The role of these receptors in organ transplant rejection, graft-versus-host disease, and ischemic reperfusion injury will also be reviewed. The potential of anti-adhesion therapy to prolong organ transplant survival will be discussed in both animal and patient studies.
Export Options
About this article
Cite this article as:
Noti D. John, Expression and Function of the Leukocyte Integrins in Organ Transplant Rejection, Current Medicinal Chemistry 2004; 11 (4) . https://dx.doi.org/10.2174/0929867043455945
DOI https://dx.doi.org/10.2174/0929867043455945 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Overlap Syndrome of Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea: A Two-Faced Janus
Current Respiratory Medicine Reviews Recent Development of Hydrogen Sulfide Therapeutics in the Treatment of Cardiovascular Diseases
Current Topics in Medicinal Chemistry Gastric Cytoprotection Beyond Prostaglandins: Cellular and Molecular Mechanisms of Gastroprotective and Ulcer Healing Actions of Antacids
Current Pharmaceutical Design Intravenous Glycoprotein IIb / IIIa Antagonists: Their Benefits, Problems and Future Developments
Current Pharmaceutical Design Neuroprotective Efficacy of the Peroxisome Proliferator-Activated Receptor-γ Ligand in Chronic Cerebral Hypoperfusion
Current Neurovascular Research Molecular and Cellular Pathways as a Target of Therapeutic Hypothermia: Pharmacological Aspect
Current Neuropharmacology The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism?
Current Drug Targets Adverse Effects of Cigarette Smoke and Induction of Oxidative Stress in Cardiomyocytes and Vascular Endothelium
Current Pharmaceutical Design Rho as a Target to Promote Repair: Translation to Clinical Studies with Cethrin
Current Pharmaceutical Design The Meaning of Different Forms of Structural Myocardial Injury, Immune Response and Timing of Infarct Necrosis and Cardiac Repair
Current Vascular Pharmacology AMPK in Neurodegenerative Diseases: Implications and Therapeutic Perspectives
Current Drug Targets Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical Applications
Current Vascular Pharmacology Characterization of Adipose-Derived Stem Cells: An Update
Current Stem Cell Research & Therapy Chinese Herbal Medicine for Hyperlipidaemia: A Review Based on Data Mining from 1990 to 2016
Current Vascular Pharmacology Vitamin D/VDR in Acute Kidney Injury: A Potential Therapeutic Target
Current Medicinal Chemistry Efficient Synthesis of Novel 3-(5-(2-Hydroxy-2-Phenylethylsulfonyl)-4- Phenyl-4H-1,2,4-Triazol-3-yl)-1,8-Naphthyridin-4(1H)-Ones
Letters in Organic Chemistry subject Index To Volume 1
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents The Update of NGAL in Acute Kidney Injury
Current Protein & Peptide Science HSP27 Protects the Blood-Brain Barrier Against Ischemia-Induced Loss of Integrity
CNS & Neurological Disorders - Drug Targets ADAM17 as a Therapeutic Target in Multiple Diseases
Current Pharmaceutical Design